These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 7488320

  • 1. Effect of isocarbacyclin methyl ester incorporated in lipid microspheres on experimental models of peripheral obstructive disease.
    Murakami T, Sawada K, Taneda K, Hayashi M, Katsuura Y, Tanabe H, Kiyoki M, Araki H.
    Arzneimittelforschung; 1995 Sep; 45(9):991-4. PubMed ID: 7488320
    [Abstract] [Full Text] [Related]

  • 2. Effect of isocarbacyclin methyl ester incorporated into lipid microspheres on cutaneous blood flow in rat.
    Sawada K, Taneda K, Katsuura Y, Tanabe H, Kiyoki M, Araki H.
    Arzneimittelforschung; 1995 Sep; 45(9):988-90. PubMed ID: 7488319
    [Abstract] [Full Text] [Related]

  • 3. Effect of beraprost sodium on peripheral circulation insufficiency in rats and rabbits.
    Murai T, Muraoka K, Saga K, Sakai A, Sato N, Amemiya K, Yajima M, Murata T, Umetsu T, Nishio S.
    Arzneimittelforschung; 1989 Aug; 39(8):856-9. PubMed ID: 2510741
    [Abstract] [Full Text] [Related]

  • 4. Vasorelaxant effect of isocarbacyclin methyl ester incorporated into lipid microspheres on isolated canine arteries.
    Sawada K, Aoki K, Katsuura Y, Tanabe H, Kiyoki M, Araki H.
    Arzneimittelforschung; 1995 Sep; 45(9):985-8. PubMed ID: 7488318
    [Abstract] [Full Text] [Related]

  • 5. Ex vivo anti-platelet effects of isocarbacyclin methyl ester incorporated in lipid microspheres in rabbits.
    Inoue K, Aoki Y, Hayashi M, Kitahara S, Tanabe H, Kiyoki M, Araki H.
    Arzneimittelforschung; 1995 Sep; 45(9):980-4. PubMed ID: 7488317
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the effect of Lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats.
    Goto J, Araki H, Otomo S, Aihara H.
    Drugs Exp Clin Res; 1986 Sep; 12(11):917-21. PubMed ID: 3816509
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of the isocarbacyclin methyl ester clinprost incorporated into lipid microspheres, in focal ischemia of stroke-prone spontaneously hypertensive rats.
    Yae T, Araki H, O-ogami Y, Iwasaki K, Tanabe H, Fujiwara M.
    Arzneimittelforschung; 1997 Nov; 47(11):1200-3. PubMed ID: 9428973
    [Abstract] [Full Text] [Related]

  • 9. Effect of YM-254890, a specific Galphaq/11 inhibitor, on experimental peripheral arterial disease in rats.
    Uemura T, Takamatsu H, Kawasaki T, Taniguchi M, Yamamoto E, Tomura Y, Uchida W, Miyata K.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):154-61. PubMed ID: 16566917
    [Abstract] [Full Text] [Related]

  • 10. Effects of R-102444, an orally active 5-HT2A receptor antagonist, in rat models of peripheral vascular disease.
    Ogawa T, Sugidachi A, Tanaka N, Fujimoto K, Asai F.
    Vascul Pharmacol; 2004 Feb 24; 41(1):7-13. PubMed ID: 15135326
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effect of prostaglandin E1 on laurate-induced peripheral vascular occlusive sequelae in rabbits: optimized topical formulation with beta-cyclodextrin derivative and penetration enhancer HPE-101.
    Adachi H, Irie T, Uekama K, Manako T, Yano T, Saita M.
    J Pharm Pharmacol; 1992 Dec 24; 44(12):1033-5. PubMed ID: 1361553
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of the peripheral vascular diseases with prostaglandin].
    Miyauchi Y.
    Nihon Rinsho; 1994 Aug 24; 52(8):2182-6. PubMed ID: 7933609
    [Abstract] [Full Text] [Related]

  • 13. A multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders.
    Mizushima Y, Shiokawa Y, Homma M, Kashiwazaki S, Ichikawa Y, Hashimoto H, Sakuma A.
    J Rheumatol; 1987 Feb 24; 14(1):97-101. PubMed ID: 3553591
    [Abstract] [Full Text] [Related]

  • 14. Effect of (+/-)-2-(dimethylamino)-1-[[o-(m-methoxyphenethyl)phenoxy] methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease.
    Hara H, Shimada H, Kitajima A, Tamao Y.
    Arzneimittelforschung; 1991 Jun 24; 41(6):616-20. PubMed ID: 1930349
    [Abstract] [Full Text] [Related]

  • 15. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K, Ikeda U, Murakami Y, Yoshioka T, Shimada K.
    Am Heart J; 2003 Feb 24; 145(2):330-3. PubMed ID: 12595852
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of OP-41483.alpha-CD, a prostacyclin analog, on peripheral vascular lesion models in rats.
    Wakitani K, Takakuwa T, Sugioka M, Fujitani B, Aishita H.
    Jpn J Pharmacol; 1992 May 24; 59(1):57-63. PubMed ID: 1507658
    [Abstract] [Full Text] [Related]

  • 17. Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy.
    Hoshi K, Mizushima Y, Kiyokawa S, Yanagawa A.
    Drugs Exp Clin Res; 1986 May 24; 12(8):681-5. PubMed ID: 3757764
    [Abstract] [Full Text] [Related]

  • 18. The effect of prostaglandin E1 incorporated in lipid microspheres on thrombus formation and thrombus disaggregation and its potential to target to the site of vascular lesions.
    Sim AK, McCraw AP, Cleland ME, Aihara H, Otomo S, Hosoda K.
    Arzneimittelforschung; 1986 Aug 24; 36(8):1206-9. PubMed ID: 3778557
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective effect of TTC-909, an isocarbacyclin methyl ester incorporated in lipid microspheres, on hippocampal delayed neuronal death of stroke-prone spontaneously hypertensive rats.
    Yamashita K, Kataoka Y, Nakashima MN, Yamashita YS, Tanabe H, Araki H, Niwa M, Taniyama K.
    Jpn J Pharmacol; 1996 Aug 24; 71(4):351-5. PubMed ID: 8886935
    [Abstract] [Full Text] [Related]

  • 20. Treatment of established collagen induced arthritis with prostaglandin E1 incorporated in lipid microspheres.
    Moriuchi-Murakami E, Yamada H, Ishii O, Kikukawa T, Igarashi R.
    J Rheumatol; 2000 Oct 24; 27(10):2389-96. PubMed ID: 11036835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.